Morristown-based JLL said Feb. 17 that it has been exclusively retained to market 1 Avon Place, a 235,000-square-foot Class A research and development facility in Suffern, N.Y., for sale and/or lease on behalf of Westchester County-based biotechnology company Regeneron. Suffern is adjacent to Mahwah.
The three-story property, which was the former innovation center for global beauty brand Avon, is purpose-built for research and development and offers a highly flexible layout supported by existing lab, office and technical infrastructure. The site has flexible zoning that allows for a broad range of uses and future redevelopment potential, including continued research and development use as well as conversion to health care, data center and other permitted uses, positioning the asset to appeal to a wide spectrum of owner-users, investors and tenants.
1 Avon Place, on nearly 10 acres, is fully equipped with institutional-grade infrastructure, including 34 fume hoods, DI water, compressed air and vacuum systems, natural gas to bench tops, a gas detection system, dual 900-ton chillers, 4,000 amps of total power and a 750-kilowatt emergency generator.
Existing uses span clinical testing, pilot plant operations, microbiology and analytical labs, executive offices and technical service areas, offering immediate usability for life sciences, biotech and R&D users.
The property is 30 minutes from New York City at the crossroads of Interstate 287, the New York State Thruway and Route 17, offering strong regional accessibility and proximity to Suffern’s downtown, with Suffern Station less than half a mile away. The submarket is rapidly growing, with more than 400 residential units built or proposed since 2023 as well as an expanding medical market.
The property features 565 parking spaces, 75,000-square-foot floor plates, a glass atrium lobby, 15.5-foot slab-to-slab heights, 24/7 gated security and three covered loading docks. The basement level serves as a hub for technical service operations.
The JLL team marketing the property is being led by Vice Chairman Dan Loughlin, Senior Managing Director Jeremy Neuer and Vice President Matt Loughlin.
